Health Condition 1: H60-H95- Diseases of the ear and mastoid process
Conditions
Interventions
Intervention1: GABAPENTIN: Gabapentin is an anticonvulsant that has antinociceptive properties. It binds the alpha 8 subunits of voltage dependent calcium ion channels and blocks the development of hy
Mitigation of tachykinin neurotransmitter activity by gabapentin has been postulated to play a role (Guttuso et al., 2003).
Control Intervention1: CLONIDINE: The alpha-agonist clonidine has also shown
Quintin et al., 1991).
In the study by Pandey et al. (2006) on two hundred and fifty patients scheduled for
laparoscopic Cholecystectomy, gabapentin as premedication effectively suppresses nau
on Postoperative Pain Intensity Levels, incidence of nausea and vomiting in patients undergoing elective mastoidectomy surgery under gen
Sponsors
Dr Vimal M
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patient posted for Mastoidectomy surgery 2)18-60 years of age 3)ASA physical status 1&2
Exclusion criteria
Exclusion criteria: 1)Known allergy to gabapentin and clonidine 2)Patient refusal 3)Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the post operative pain intensity levels between the oral clonidine and oral gabapentin groupsTimepoint: First 12 hours postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the incidence of postoperative nausea & vomiting between the two groupsTimepoint: First 12 hours postoperatively | — |
Countries
India
Contacts
Public ContactDr Vimal M
ESIC Medical College
Outcome results
None listed